- ICH GCP
- US Clinical Trials Registry
- Search trials
Søg i kliniske forsøg efter: COMVIGEN (ChulaCov19 BNA159.2) vaccine (50 mcg)
I alt 5 resultater
-
Technovalia, Pty LtdChulalongkorn University; Southern Star Research Pty Ltd.; BioNet-AsiaAktiv, ikke rekrutterendeCOVID-19, SARS CoV 2-infektionAustralien
-
Chulalongkorn UniversityHIV-NAT, Thai Red Cross - AIDS Research Centre; Chula Clinical Research...RekrutteringSikkerhed ved en enkelt dosis COMVIGEN-vaccine | Reaktogenicitet af en enkelt dosis COMVIGEN-vaccine | Immunogenicitet af en enkelt dosis COMVIGEN-vaccine | Sikkerhed ved en enkelt dosis BIVALENT Pfizer/BNT-vaccine | Reaktogenicitet af en enkelt dosis BIVALENT Pfizer/BNT-vaccine | Immunogenicitet...Thailand
-
Chulalongkorn UniversityBioNet-Asia; Chula Clinical Research Center (Chula CRC), Faculty of Medicine... og andre samarbejdspartnereRekrutteringSikkerhed for 25 ug ChulaCov19-BNA159 mRNA-vaccine | Tolerabilitet af 25 ug ChulaCov19-BNA159 mRNA-vaccine | Immunrespons af 25 ug ChulaCov19-BNA159 mRNA-vaccine | Sikkerhed for 50 ug ChulaCov19-BNA159 mRNA-vaccine | Tolerabilitet af 50 ug ChulaCov19-BNA159 mRNA-vaccine | Immunrespons af 50 ug... og andre forholdThailand
-
The University of QueenslandSyneos Health; Coalition for Epidemic Preparedness InnovationsAfsluttetCovid19 | SARS-CoV-2Australien
-
ALK-Abelló A/SAfsluttetAllergi | Rhinitis | Konjunktivitis | Rhinoconjunctivitis